Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Uteron Pharma SA

Division of Allergan PLC
www.odyssea-pharma.be

Latest From Uteron Pharma SA

Nonprofit Medicines360 Provides Affordable Contraception, Women’s Health

Emerging Company Profile: Medicines360 and partner Allergan launched the IUD Liletta in 2015, so now the nonprofit pharmaceutical company is looking for additional contraceptives and women’s health products.

Commercial StartUps and SMEs

Actavis’ Transformative Dealmaking

A steady stream of M&A and licensing activity, starting with the buyout of Andrx in 2006, spurred Actavis’ a.k.a. Watson’s transformation into a global specialty pharma. This led the way to the 2012 merger with Actavis and now the proposed buyout of Forest, creating a new, global specialty and generics player.

BioPharmaceutical Strategy

Watson’s Transformative Deal-Making

A steady stream of M&A and licensing activity, starting with the buyout of Andrx in 2006, spurred Watson’s transformation into a global specialty pharma. This led the way to the 2012 merger with Actavis and now the proposed buyout of Forest, creating a new, global specialty and generics player.

BioPharmaceutical Business Strategies

Fertility Market Poised For Growth Spurt After Fallow Decade

Late-stage pipeline is dominated by follicle stimulating hormones, split between “biobetters” and biosimilars. Next-generation oxytocin antagonists are leading candidates for the next novel entities in infertility.

BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Medical Devices
    • Implantable Devices
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Belgium
  • Parent & Subsidiaries
  • Allergan PLC
  • Senior Management
  • Stijn Van Rompay, CEO
    Steven Peters, CFO
    Jean-Michel Foidart, CSO
  • Contact Info
  • Uteron Pharma SA
    Phone: 04 220 9630
    Rue du Travail 16
    Grace Hollogne, B-4460
    Belgium
Advertisement
Advertisement
UsernamePublicRestriction

Register